Mannatech Issued 99th Patent

View Mannatech Profile

2/3/2015

COPPELL, TEXAS - February 2, 2015 — Mannatech, Incorporated, the founder of the M5MSM (Mission 5 MillionSM) social entrepreneurial movement, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology solutions, has been issued its 99th patent, validating and demonstrating its position as the leading developer of nutritional technology. This patent was received in Japan for its PhytoMatrix formulation, a supplement with all natural vitamins and plant-based minerals.

“By receiving multiple patents in multiple countries, Mannatech has established itself around the world as the leading developer of unique, high quality health and wellness technology,” said Dr. Rob Sinnott, CEO and Chief Science Officer at Mannatech. “Mannatech is unique in the nutritional supplement field for the multiple patents our products have received around the world. This, along with product benefits established in published human clinical trials, clearly demonstrates the soundness of our nutrition technology. Our PhytoMatrix product is an excellent example of how Mannatech supports overall wellness through a formulation that provides a nutritional boost to our everyday diet*.”

The Certificate of Grant for Mannatech’s PhytoMatrix formulation in Japan was received on Nov. 7, 2014. The patent will remain in effect for 20 years from the date of filing. There are currently seven patents issued in major global markets to Mannatech for the technology pertaining to its PhytoMatrix formulation.

Mannatech’s PhytoMatrix formulation has been available since 2006 and is sold around the world. It is the only vitamin and mineral supplement on the market that contains minerals from hydroponically grown Indian Mustard plant and food-sourced vitamins and phytonutrients from fruits and vegetables. The PhytoMatrix formulation is gluten-free, suitable for vegetarian diets and is NSF certified.

Overall, 99 patents have been issued to Mannatech in multiple global markets for the technology pertaining to its Ambrotose®, Ambrotose AO®, GI-ProBalance®, and PhytoMatrix® product formulations and in the field of biomarker assays. Because of the unique nature of Mannatech’s technology, the company has a history of diligently and successfully defending the strength and validity of its patents against companies that sell infringing products.

In addition to Mannatech’s extensive patent portfolio, numerous products have been further validated by research conducted by independent scientists and published in peer-reviewed scientific journals. To date, 17 human clinical trials have been published, 13 of which were double-blind, placebo-controlled studies -- the gold standard for product validation.